Key facts
- This page summarizes Avinash Amin's Form 4 filing for Neuronetics, Inc. (STIM).
- 3 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 17 Jun 2026, 16:57.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Other
Other
Other
Additional SEC filing notes
Footnote F1
The reported transactions involved a transfer of shares received by Avinash Amin as director compensation to each of Madryn Health Partners II, LP ("Health Partners"), Madryn Health Partners II (Cayman Master), LP ("Cayman Master") and Madryn Select Opportunities, LP ("Select Opportunities") as provided for in each fund's respective partnership agreement. Each transfer was made for no consideration.
Footnote F2
Represents shares of common stock transferred to Health Partners.
Footnote F3
Represents shares of common stock transferred to Cayman Master.
Footnote F4
Represents shares of common stock transferred to Select Opportunities.